NovaBridge Biosciences NBP
NASDAQ NBP
$1.28 -0.09 (-6.57%)
As of: Oct 22, 2026 · 1:07 PM EDT

NovaBridge Biosciences (NBP) EBT Margin (2019 - 2023)

Updated

NovaBridge Biosciences (NBP) recorded EBT Margin of -738200.00% in Q4 2023, down 735590.16 percentage points from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) EBT Margin (2019 - 2023) Analysis & Trends

For FY2023, NovaBridge Biosciences reported EBT Margin of -13009.02%, down 3911.66 percentage points from FY2022.

  • Annual EBT Margin has declined for three straight years, with a five-year change of -12263.20 percentage points (FY2018 to FY2023).
  • Across earlier years, EBT Margin came in at -9097.36% in FY2022 (-6445.04 pp), -2652.32% in FY2021 (-2683.64 pp), 31.32% in FY2020 (+4871.42 pp) and -4840.10% in FY2019 (-4094.28 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn 0.13%
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn 25.18%
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn -4.11%
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn 29.63%
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn 18.19%
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn 27.53%
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn -131.41%
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn -4.34%
10 NovaBridge Biosciences 122.58 Mn -673.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -738,200.00%
Sep 30, 2023 -2,609.84%
Jun 30, 2023 -17,332.08%
Dec 31, 2020 68.75%
Sep 30, 2019 -1,640.29%
API Access

NovaBridge Biosciences EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NBP&period=max&api_key=YOUR_API_KEY